100% committed to ending dementia. For good.

Donate

All in to end Alzheimer disease.

CLEAR is the only Canadian foundation that directs 100% of funds raised to promising scientific research into the cause, prevention, and treatment of Alzheimer disease and other dementias.

About us

Because it’s clear: the only path to a cure is more research.

pexels-liza-summer-6383183@2x

650K+

people living with dementia in Canada

Even more alarmingly, by 2031 this number is expected to exceed 1 million.

40

research projects funded by CLEAR

Each of these projects has contributed to our collective understanding of dementia.

8th

leading cause of death in Canada

Every year, over 6,000 Canadians die from the disease. That’s 16 loved ones lost each day.

$15M+

of funding provided to researchers

We will keep funding promising research until we have the cure the world has been waiting for.

Past & Present Research

Human islet amyloid polypeptide aggregation, the missing link between type 2 diabetes and Alzheimer’s disease?

Q: What did we learn? Dr. Zhang’s research focused on creating a better understanding of why type 2 diabetes patients have an increased risk of developing Alzheimer disease. This research identified the important role of human islet amyloid polypeptide (hIAPP) in diabetes-induced dementia. Targeting hIAPP may be a valid approach for preventing and treating dementia…

See This Project

Examining the effect of aerobic exercise on cognitive decline in older men and women, with mild cognitive impairment.

ABSTRACT Worldwide, one new case of dementia is detected every four seconds; there is currently no effective drug therapy. Given the greater prevalence of Alzheimer’s disease and its faster rate of progression from mild cognitive impairment to Alzheimer’s disease in women compared to men, it is essential to assess sex differences in studies relating to…

See This Project

Preclincal development of a disease modifying small molecule therapy for Alzheimer disease

ABSTRACT No medications exist that can stop or even slow the progression for Alzheimer Disease (AD). The two pathological hallmarks of AD are protein aggregates deposited in the brain that are known as tangles and plaques. These aggregates form from inappropriately modified forms of the microtubule associated protein tau and peptide fragments, known as Aβ…

See This Project

The effects of resistance training on myelin and blood-based biomarkers of neuroplasticity in older adults

ABSTRACT We are studying if strength training exercises can reduce myelin loss and preserve cognitive abilities in adults with cognitive impairment due to vascular risk factors (e.g., high blood pressure), also known as vascular cognitive impairment (VCI). Worldwide, VCI is the second most common cause of dementia and it is associated with myelin loss. Myelin…

See This Project
See all research projects

Together, we can find a cure for Alzheimer disease.

Donate

Sign up for Untangling Alzheimers, our newsletter: